Search for Clinical Trial Results

Sponsored By

Meningeal Carcinomatosis - 25 Studies Found

Status Study
Not yet recruiting Study Name: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis
Condition: Meningeal Carcinomatosis
Date: 2015-10-26
Interventions: Drug: methotrexate The quantity of methotrexate is different in the two groups.
Terminated Study Name: Depocyt® With Sorafenib in Neoplastic Meningitis
Condition: Neoplastic Meningitis
Date: 2009-08-24
Interventions:
  • Drug: DepoCyt Patients were to
Completed Study Name: A Pilot Study of Bevacizumab for Neoplastic Meningitis
Condition: Neoplastic Meningitis
Date: 2009-06-18
Interventions: Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks.
Terminated Study Name: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
Condition: Neoplastic Meningitis
Date: 2007-08-13
Interventions:
  • Drug: DepoCyt Starting dose of
Completed Study Name: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis
Condition: Neoplastic Meningitis
Date: 2007-12-21
Interventions:
  • Drug: Topotecan

Terminated Study Name: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
Condition: Leptomeningeal Carcinomatosis
Date: 2007-09-07
Interventions: Drug: RTA 744 Aqueous solution of RTA 744 is packaged in 5 ml vials - 1 mg/ ml. The drug is mixed in D10
Terminated Study Name: Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases
Condition: Meningeal Carcinomatosis
Date: 2012-10-22
Interventions: Procedure: lumbar puncture
Terminated Study Name: DepoCyt for Active Lymphomatous or Leukemic Meningitis
Condition:
  • Neoplastic Meningitis
  • Lymphoma, B Cell

Date: 2007-08-31
Interventions: Drug: cytarabine liposome injection 50 mg intrathecal every 14 days for 8 doses, then every 28 days for
Recruiting Study Name: Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
Condition:
  • Metastatic Breast Cancer
  • Carcinomatous Meningitis

Date: 2011-05-24
Interventions: Drug: Trastuzumab One injection per week during 8 weeks by lumbar puncture or Ommaya Reservoir. 4 levels
Recruiting Study Name: Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
Condition: Meningeal Carcinomatosis
Date: 2013-03-18
Interventions: Drug: 2B3-101 50 mg/m2 2B3-101 intravenous 3-weekly administration
Next >>>